Table 1.
CGL | FPL | AGL | APL | |
---|---|---|---|---|
Age range of onset | Infancy to early childhood |
Childhood through adulthood |
Childhood through adulthood |
Childhood through adulthood |
Approximate gender distribution (male:female) |
1:1-2 | 1:1-2a | 1:3 | 1:4 |
Fat loss locations | ||||
Face and neck | X | X | X | |
Chest/trunk | X | + | X | X |
Upper extremities | X | X | X | X |
Lower extremities | X | X | X | |
Intra-abdominal | X | + | ||
Fat accumulation/sparing | ||||
Face and neck | + | |||
Hips and buttocks | + | |||
Lower extremities | + | |||
Intra-abdominal | + | + | + | |
Other findings | ||||
Accelerated linear growth | + | |||
Acromegaloid features | + | |||
Umbilical prominence | + | |||
Panniculitis | + | |||
Hepatomegaly | + | + | + | |
Splenomegaly | + | + | ||
Acanthosis nigricans | + | + | + | |
Hirsutism | + | + | + | |
Hyperphagia | + | + | + | |
Hypogonadism | + | + | ||
Hyperandrogenism in females | + | + |
Abbreviations: AGL = acquired generalized lipodystrophy; APL = acquired partial lipodystrophy; CGL = congenital generalized lipodystrophy; FPL = familial partial lipodystrophy; X = essential finding; + = finding may be present.
FPL is typically more readily recognized in females and affects females more severely.